Steven B Ratoff's Net Worth
-$10.5 Thousand
Who is Steven B Ratoff?
Steven B Ratoff does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include EAGLE PHARMACEUTICALS, INC., NOVADEL PHARMA INC, TorreyPines Therapeutics, Inc., CIMA LABS INC, and INKINE PHARMACEUTICAL CO INC.
SEC CIK
Steven B Ratoff's CIK is 0001054941
Past Insider Trading and Trends
2007 was Steven B Ratoff's most active year for acquiring shares with 10 total transactions. Steven B Ratoff's most active month to acquire stocks was the month of July. 2004 was Steven B Ratoff's most active year for disposing of shares, totalling 26 transactions. Steven B Ratoff's most active month to dispose stocks was the month of September. 2006 saw Steven B Ratoff paying a total of $550,068.20 for 441,975 shares, this is the most they've acquired in one year. In 2016 Steven B Ratoff cashed out on 10,000 shares for a total of $750,091.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
EAGLE PHARMACEUTICALS, INC. (EGRX) Snapshot price: $5.33
InvestorSteven B Ratoff owns 19,374 units of Common Stock, $0.001 par value which is worth $103,263.42 and 27,364 units of Common Stock which is worth $145,850.12. From 2014 to 2023 Steven B Ratoff acquired a total of 28,004 shares in EAGLE PHARMACEUTICALS, INC. at a cost of $134,058.50, Steven also disposed a total of 10,000 shares of EAGLE PHARMACEUTICALS, INC. equalling to $750,091.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
| +34.51% | 7.02K |
$7.33 | $51,433.20 | 27.36K |
Apr 8
| |||
Form 4
| +13.00% | 2.34K |
$8.78 | $20,545.20 | 20.34K |
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
| +14.94% | 2.34K |
$4.04 | $9,453.60 | 18K |
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 4
| +17.56% | 2.34K |
$0.90 | $2,106.00 | 15.66K |
Dec 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
| -31.23% | -6.05K |
$43.90 | -$699,570.50 | 13.32K |
Apr 3 - Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 8
| |||
Form 4
| +106.99% | 10.01K |
—
|
—
| 19.37K |
Feb 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NOVADEL PHARMA INC No price found
President and CEOSteven B Ratoff owns 560,000 units of Common Stock and 1,560,000 units of Common Stock $0.001 par value.acquired a total of 1,560,000 shares in NOVADEL PHARMA INC at a cost of $445,232.11.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
| +178.57% | 1M |
$0.16 | $159,210.89 | 1.56M |
Dec 8 - Dec 11
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Oct 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 8
| |||
Form 4
| +115.38% | 300K |
—
|
—
| 560K |
Feb 6
| |||
Form 4
| +2.33% | 5.91K |
$0.73 | $4,313.94 | 260K |
Aug 28
| |||
Form 4
| +2.54% | 6.3K |
$0.65 | $4,095.00 | 254.09K |
Aug 24
| |||
Form 4
| +18.85% | 39.3K |
$0.65 | $25,545.00 | 247.79K |
Aug 23
| |||
Form 4
| +2.16% | 4.4K |
$0.64 | $2,830.08 | 208.49K |
Aug 22
| |||
Form 4
| +32.45% | 50K |
$0.61 | $30,350.00 | 204.09K |
Aug 21
| |||
Form 4
| +19.37% | 25K |
$0.60 | $14,925.00 | 154.09K |
Aug 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 16
| |||
Form 4
|
∞
| 129.09K |
$1.58 | $203,962.20 | 129.09K |
Apr 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TorreyPines Therapeutics, Inc. No price found
InvestorSteven B Ratoff owns 81,208 units of Common Stock. From 2005 to 2008 Steven B Ratoff acquired a total of 299,958 shares in TorreyPines Therapeutics, Inc. at a cost of $644,627.90.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
| +159.87% | 49.96K |
$6.93 | $346,106.00 | 81.21K |
Dec 26 - Dec 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
∞
| 250K |
$1.19 | $298,521.90 | 250K |
May 16 - May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CIMA LABS INC No price found
Chairman and Interim CEOSteven B Ratoff used to own units in Common Stock but no longer holds any shares there. In the year 2004 Steven B Ratoff filed a total of 2 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -6.30K |
$34.00 | -$214,200.00 |
0
|
Aug 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 11 - Jun 18
| |||
| No matching records found | |||||||||
INKINE PHARMACEUTICAL CO INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
| No matching records found | |||||||||